Search for: "ROCHE v. UNITED STATES ATTORNEY GENERAL"
Results 21 - 40
of 55
Sort by Relevance
|
Sort by Date
25 May 2011, 11:46 pm
United States, 429 U.S. 17 (1976), and Precision Instruments Manufacturing Co. v. [read post]
16 May 2011, 1:48 am
The action is being brought by the Attorney General Dominic Grieve, which gives an indication of the seriousness of the allegations. [read post]
1 Mar 2011, 6:37 am
United States and Board of Trustees of Leland Stanford Junior University v. [read post]
3 Jan 2011, 9:45 pm
Medicare Fraud: CLINIC OWNERS GET PRISON FOR STEALING MEDICARE FUNDS, United States v. [read post]
1 Nov 2010, 7:38 am
Roche Molecular Systems, Inc. [read post]
1 Nov 2010, 7:13 am
Roche Molecular Systems (09-1159). [read post]
22 Jun 2010, 12:41 pm
United States (09-977); United States v. [read post]
21 Dec 2009, 5:24 am
Century City Apartments Property Services CC and Another v Century City Property Owners Association (Afro-IP) Spain A branding miracle from: from bullring to shop windows (Class 46) Ukraine Ukrainian Higher Economic Court denies Ferrero’s claim on Raffaello trade mark infringement: Group Ferrero v Landrin (Class 46) United Kingdom EWHC on compensation for employee inventors whose patents are particularly beneficial to employers: Shanks… [read post]
25 Nov 2009, 3:00 am
(IPKat) Maximising IP and intangible assets: new report (IP finance) (Innovationpartners) Protecting developing countries through the Trips Agreement: What is the real state of play? [read post]
14 Nov 2008, 2:12 am
Vergeer en Zonen before District Court of The Hague (Class 46) Poland Polish Patent Office partially invalidates VOGUE registration for Advance Magazine Publishers (Class 46) Poland, brands and billboards (Class 46) South America South American cooperation plan in IP rights (IP tango) Spain Spanish Ministry of Employment auctioning brand ‘Galerías Preciados’ (Class 46) Russia Interbrand’s ranking of Russia’s most valuable brands (IP finance)… [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
